Cargando…

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) are the most common cancers in the head and neck. Therapeutic response-related genes (TRRGs) are closely associated with carcinogenesis and prognosis in HNSCC. However, the clinical value and prognostic significance of TRRGs are still unclear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Cheng, Chen, Yuebing, Pan, Jianji, Lu, Qiongjiao, Ji, Pengjie, Lin, Shuiqin, Liu, Chunfeng, Lin, Shaojun, Li, Meifang, Zong, Jingfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142243/ https://www.ncbi.nlm.nih.gov/pubmed/37106442 http://dx.doi.org/10.1186/s12864-023-09325-1

Ejemplares similares

Individualized Concurrent Chemotherapy for Patients with Stage III–IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy
por: Ji, Pengjie, et al.
Publicado: (2023)

Identification of pyroptosis‐related gene prognostic signature in head and neck squamous cell carcinoma
por: Li, Zhanzhan, et al.
Publicado: (2022)

Identification of immune‐related genes contributing to head and neck squamous cell carcinoma development using weighted gene co‐expression network analysis
por: Guo, Qiaojuan, et al.
Publicado: (2023)

RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma
por: Lin, Cheng, et al.
Publicado: (2022)

Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy
por: Lu, Tianzhu, et al.
Publicado: (2016)

The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma
por: Ming, Ruijie, et al.
Publicado: (2021)

Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era
por: Chen, Zhuhong, et al.
Publicado: (2017)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma
por: Lin, Cheng, et al.
Publicado: (2022)

High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2021)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma
por: Fang, Jiayu, et al.
Publicado: (2021)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas
por: Tang, Shouyi, et al.
Publicado: (2022)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
por: Qian, Xiaoyu, et al.
Publicado: (2021)

Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients
por: Xiao, Youping, et al.
Publicado: (2015)

The Prognostic Signature of Head and Neck Squamous Cell Carcinoma Constructed by Immune-Related RNA-Binding Proteins
por: Ming, Ruijie, et al.
Publicado: (2022)

Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020)

Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021)

The Prognosis of Nasopharyngeal Carcinoma Involving Masticatory Muscles: A Retrospective Analysis for Revising T Subclassifications
por: Xiao, Youping, et al.
Publicado: (2015)

Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study
por: Xu, Yuanji, et al.
Publicado: (2017)

Does MRI-Detected Cranial Nerve Involvement Affect the Prognosis of Locally Advanced Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiotherapy?
por: Zong, Jingfeng, et al.
Publicado: (2014)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

Mast cell marker gene signature in head and neck squamous cell carcinoma
por: Cai, Zhimou, et al.
Publicado: (2022)

Identification of Prognostic Markers for Head and NeckSquamous Cell Carcinoma Based on Glycolysis-Related Genes
por: Ren, Xiaobin, et al.
Publicado: (2022)

Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas
por: Wei, Zhengyu, et al.
Publicado: (2023)

Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma
por: Wang, Yingying, et al.
Publicado: (2020)

A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma
por: Huang, Chao, et al.
Publicado: (2022)

HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma
por: Zhao, Hongyu, et al.
Publicado: (2022)

A Novel Prognostic Signature Based on Metabolism-Related Genes to Predict Survival and Guide Personalized Treatment for Head and Neck Squamous Carcinoma
por: Li, Ying, et al.
Publicado: (2021)

Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status
por: Zheng, Wei, et al.
Publicado: (2016)

SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2021)

Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma
por: Qiang, Weijie, et al.
Publicado: (2021)

A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma
por: Liu, Guancheng, et al.
Publicado: (2018)

Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma
por: Yang, Cai, et al.
Publicado: (2020)

A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Mai, Zizhao, et al.
Publicado: (2022)

Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma
por: Liu, Jie, et al.
Publicado: (2022)

A key genomic signature associated with lymphovascular invasion in head and neck squamous cell carcinoma
por: Zhang, Jian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f4hcj2mlae9ag3rkp7v5uk70kj